Hot Pursuit     10-Mar-25
Zydus Life gets USFDA approval for Ketoconazole Shampoo, 2%
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole shampoo, 2%.
Ketoconazole shampoo, a generic version of Nizoral Shampoo (2%), is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions. It will be produced at the group’s topical manufacturing site at Changodar, Ahmedabad.

According to IQVIA MAT data for January 2025, Ketoconazole shampoo had annual sales of $68.89 million in the United States.

With this approval, Zydus Lifesciences now holds 418 USFDA approvals, having filed 483 ANDAs since FY 2003-04.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Shares of Zydus Lifesciences rose 0.67% to Rs 907.20 on the BSE.

Previous News
  Zydus receives USFDA nod for Ivermectin and Dapsone tablets
 ( Hot Pursuit - 02-Mar-26   11:29 )
  Zydus receives USFDA approval for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
 ( Corporate News - 28-Feb-26   11:54 )
  Zydus achieves positive clinical data for Pembrolizumab biosimilar FYB206
 ( Corporate News - 27-Feb-26   19:06 )
  Zydus Lifesciences Ahmedabad injectables unit clears USFDA inspection
 ( Hot Pursuit - 20-Feb-26   10:52 )
  Zydus launches Anyra for treatment of major retinal disorders
 ( Hot Pursuit - 19-Feb-26   10:55 )
  Zydus launches India's first indigenously developed biosimilar - Anyra™
 ( Corporate News - 19-Feb-26   10:52 )
  Zydus receives USFDA approval for Bosentan 32 mg tablets
 ( Corporate News - 18-Feb-26   19:24 )
  Zydus Lifesciences launches PEPAIR, India’s first affordable OPEP device at Rs 990
 ( Hot Pursuit - 17-Feb-26   12:50 )
  Zydus launches India's first affordable OPEP device - PEPAIR™
 ( Corporate News - 17-Feb-26   12:35 )
  Zydus Lifesciences receives USFDA approval for Ammonium Lactate Cream, 12%
 ( Corporate News - 14-Feb-26   12:06 )
  Nifty slips below 25,850 mark; realty shares witness profit booking
 ( Market Commentary - Mid-Session 12-Feb-26   11:33 )
Other Stories
  UltraTech Cement board appoints Jayant Dua as managing director (designate)
  07-Mar-26   13:44
  Axis Solutions CFO Ninad Vora resigns
  07-Mar-26   13:13
  IRB Infra toll collections climb 22% YoY to Rs 746 cr in Feb’26
  07-Mar-26   11:20
  3C IT Solutions and Telecoms secures Rs 3-cr order from Credence Infotech
  07-Mar-26   10:42
  RIL's FMCG division inks MoU with Finland’s leading foods company Fazer
  07-Mar-26   08:49
  Niraj Cement Structurals bags Rs 80-cr contract from MoRTH
  07-Mar-26   07:06
  Aye Finance climbs after Q3 PAT spurts 88% YoY to Rs 43 cr
  06-Mar-26   15:12
  Liquor stocks rally after Karnataka revamps excise policy
  06-Mar-26   15:07
  Ganesha Ecosphere Ltd leads losers in 'A' group
  06-Mar-26   15:00
  Creative Newtech Ltd leads losers in 'B' group
  06-Mar-26   14:46
Back Top